Frontlight ResearchEarly access
Trial site
The Second Affiliated Hospital Zhejiang University School of Medicine
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Migraine2 trials
- Follicular lymphoma1 trial
- Thymoma and thymic carcinoma1 trial
- Phase
- Phase 33 trials
- Phase 2/31 trial
- Status
- Not yet recruiting3 trials
- Active, not recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Brise Pharmaceuticals Co., Ltd.2 trials
- Daiichi Sankyo1 trial
- Epizyme, Inc.1 trial
- Shanghai Pulmonary Hospital, Shanghai, China1 trial
- Summit Therapeutics1 trial
Running trials
Not yet recruiting
Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults
Recruiting
Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults
Recruiting
Recruiting
Active, not recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Migraine2 recruiting
- Lung cancer1 recruiting
- Thymoma and thymic carcinoma1 recruiting
Site data: ClinicalTrials.govUpdated 15 Nov 2026